(Q37318134)

19 August 2017

1 reference

title

Lacosamide for the treatment of diabetic neuropathic pain (English)

1 reference

19 August 2017

0 references

Victor Biton

1

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

19 August 2017

published in

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

1649-1660

1 reference

Diabetic peripheral neuropathic pain: recognition and management

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Lacosamide: a review of preclinical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Proteome changes associated with hippocampal MRI abnormalities in the lithium pilocarpine-induced model of convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Behavioral problems in children with newly diagnosed idiopathic or cryptogenic epilepsy attending normal schools are in majority not persistent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Clinically important changes in acute pain outcome measures: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.11.1649

10.1586/14737175.8.11.1649

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference